News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
68,774 Results
Type
Article (2138)
Company Profile (11)
Press Release (66624)
Section
Business (17148)
Career Advice (71)
Deals (4671)
Drug Delivery (5)
Drug Development (11716)
Employer Resources (6)
FDA (1888)
Job Trends (1884)
News (34042)
Policy (2450)
Tag
2027 Genetown Elite (1)
Academia (161)
Accelerated approval (8)
Adcomms (1)
Allergies (22)
Alliances (2407)
ALS (22)
Alzheimer's disease (195)
Antibody-drug conjugate (ADC) (56)
Approvals (2103)
Artificial intelligence (41)
Autoimmune disease (27)
Automation (3)
Bankruptcy (24)
Best Places to Work (1899)
BIOSECURE Act (1)
Biosimilars (41)
Biotechnology (8)
Bladder cancer (56)
Brain cancer (7)
Breast cancer (183)
Cancer (1145)
Cardiovascular disease (110)
Career advice (60)
Career pathing (1)
CAR-T (24)
Cell therapy (86)
Cervical cancer (10)
Clinical research (11255)
Collaboration (227)
Compensation (1093)
Complete response letters (2)
COVID-19 (260)
CRISPR (14)
C-suite (106)
Cystic fibrosis (32)
Data (1629)
Depression (19)
Diabetes (133)
Diagnostics (608)
Digital health (3)
Diversity, equity & inclusion (2)
Drug discovery (26)
Drug pricing (5)
Drug shortages (1)
Duchenne muscular dystrophy (34)
Earnings (13109)
Editorial (3)
Employer branding (1)
Employer resources (6)
Events (10461)
Executive appointments (129)
FDA (2639)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (2)
Funding (202)
Gene editing (34)
Gene therapy (72)
GLP-1 (148)
Government (307)
Grass and pollen (1)
Guidances (128)
Healthcare (2218)
HIV (18)
Huntington's disease (6)
IgA nephropathy (12)
Immunology and inflammation (32)
Immuno-oncology (7)
Indications (32)
Infectious disease (307)
Inflammatory bowel disease (39)
Influenza (22)
Intellectual property (19)
Interviews (10)
IPO (3564)
IRA (2)
Job creations (175)
Job search strategy (50)
JPM (7)
Kidney cancer (5)
Labor market (2)
Layoffs (28)
Leadership (5)
Legal (273)
Liver cancer (20)
Longevity (2)
Lung cancer (211)
Lymphoma (117)
Machine learning (4)
Management (2)
Manufacturing (92)
MASH (40)
Medical device (1152)
Medtech (1156)
Mergers & acquisitions (1356)
Metabolic disorders (239)
Multiple sclerosis (27)
NASH (2)
Neurodegenerative disease (50)
Neuropsychiatric disorders (14)
Neuroscience (379)
NextGen: Class of 2026 (535)
Non-profit (484)
Obesity (65)
Opinion (17)
Ovarian cancer (35)
Pain (20)
Pancreatic cancer (44)
Parkinson's disease (43)
Partnered (1)
Patents (34)
Patient recruitment (60)
Peanut (8)
People (2832)
Pharmaceutical (3)
Pharmacy benefit managers (3)
Phase 1 (2617)
Phase 2 (4711)
Phase 3 (4779)
Pipeline (1271)
Policy (5)
Postmarket research (503)
Preclinical (926)
Press Release (3)
Prostate cancer (47)
Psychedelics (6)
Radiopharmaceuticals (30)
Rare diseases (135)
Real estate (236)
Recruiting (2)
Regulatory (2698)
Reports (6)
Research institute (172)
Resumes & cover letters (11)
Rett syndrome (5)
RNA editing (2)
RSV (18)
Schizophrenia (32)
Series A (22)
Series B (21)
Sickle cell disease (17)
Spinal muscular atrophy (22)
Sponsored (7)
Startups (160)
Stomach cancer (1)
Supply chain (7)
Tariffs (2)
The Weekly (2)
Vaccines (109)
Venture capital (12)
Weight loss (33)
Women's health (6)
Date
Last 7 days (125)
Last 30 days (398)
Last 365 days (6310)
2026 (550)
2025 (6340)
2024 (5877)
2023 (5772)
2022 (6656)
2021 (6956)
2020 (5873)
2019 (4772)
2018 (3318)
2017 (3175)
2016 (2475)
2015 (2902)
2014 (1941)
2013 (1386)
2012 (1544)
2011 (1585)
2010 (1395)
Location
Africa (49)
Alabama (1)
Arizona (17)
Arkansas (1)
Asia (3734)
Australia (622)
California (2314)
Canada (510)
China (172)
Colorado (88)
Connecticut (125)
Delaware (132)
Europe (10627)
Florida (310)
Georgia (40)
Hawaii (1)
Idaho (6)
Illinois (163)
India (6)
Indiana (134)
Iowa (2)
Japan (124)
Kansas (19)
Kentucky (8)
Louisiana (6)
Maine (10)
Maryland (238)
Massachusetts (1704)
Michigan (39)
Minnesota (85)
Missouri (28)
Nebraska (1)
Nevada (19)
New Hampshire (5)
New Jersey (702)
New Mexico (2)
New York (519)
North Carolina (675)
North Dakota (2)
Northern California (1195)
Ohio (76)
Oklahoma (2)
Oregon (5)
Pennsylvania (392)
Puerto Rico (2)
Rhode Island (6)
South America (103)
South Carolina (16)
Southern California (884)
Tennessee (8)
Texas (268)
United States (8215)
Utah (48)
Virginia (46)
Washington D.C. (19)
Washington State (202)
Wisconsin (31)
68,774 Results for "c4 therapeutics.rss".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - January 26, 2026
January 27, 2026
·
1 min read
Press Releases
Neurogene Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - February 4, 2026
February 5, 2026
·
1 min read
Press Releases
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - February 4, 2026
February 5, 2026
·
1 min read
Press Releases
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - February 4, 2026
February 5, 2026
·
2 min read
Press Releases
C4 Therapeutics to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026
February 4, 2026
·
1 min read
Press Releases
Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 3, 2026
·
3 min read
Press Releases
CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - January 16, 2026
January 19, 2026
·
2 min read
Press Releases
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 3, 2026
·
1 min read
Press Releases
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - February 5, 2026
February 5, 2026
·
1 min read
Press Releases
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - February 5, 2026
February 6, 2026
·
1 min read
1 of 6,878
Next
